Home / Resources / Disasters Averted / Diabetes Wisdom Comes with Practice, Not Age

Diabetes Wisdom Comes with Practice, Not Age

Apr 3, 2018
2,838 views
 

As I am working with patients, I have so many thoughts about how different each patient is. I also have thoughts about how in this day and age, with all we have available, some people who have had diabetes for oh so many years still have no clue how to manage their diabetes.

I just met a well-educated man, new to our practice, who has had type 1 diabetes for over 20 years. He, as with many people, thought carbohydrate counting is an exact science. He just thought he hadn’t found the right tool for counting carbs yet. We let him know it is not an exact science, and neither is the way people respond to food, medication, activity, etc. In this gentleman’s case, one of the issues is that he has been injecting insulin in the same area of his abdomen for years. One side of his abdomen is now larger than the other. He thought it was just the way he was gaining weight. The endocrinologist examined him and taught him the reason his abdomen is shaped as it is is actually due to not rotating sites where he injects insulin, which can affect how his body responds to the insulin he takes. The endocrinologist taught the patient how to rotate sites and to keep a record of where he injected his insulin as he evaluates his glucose levels.

 

Lessons Learned:

  • Glucose variability has various causes. The various causes should be taught to patients.
  • Glycemic variation, among other things, can be related to lipodystrophy. Check insulin injection sites of your patients and teach to rotate sites. Read more at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014793/
  • Have realistic expectations. Carb counting (knowing how food will affect one’s glucose level) is not an exact science. This is not to say one should not learn how certain foods affect their glucose levels, but don’t expect to eat the same thing every day and expect glucose to be the same. There are so many factors in what affects one’s glucose levels, which will take learning over time. If possible, have your patient use a CGM with good records of the time of day, medication taken (how much, what time, and where medication is injected), food eaten (including amount), drink, any and all activity, and sleep. Although other factors can affect glucose, this is a good start.

Joy Pape, FNP-C, CDE
Medical Editor, Diabetes In Control

If you have a “Diabetes Disaster Averted” story, please let us know! If we feature your Disaster Averted in our Diabetes Clinical Mastery Series e-newsletter, you will receive a $25 gift card. Please click here to submit a short summary of the incident, what you feel you learned from handling the incident, and your name and title. If you prefer to remain anonymous, please let us know, but still give us your name and address (so we can send you the gift card).

Copyright © 2018 HIPER, LLC

Note: This is a test environment, the ads will not render in all positions when live.

Other content recommended for you

  1. Learn about 2 GLP-1 RA treatment options available for your adult patients with T2D
    Novo Nordisk, Inc., November 2019
  2. Do you know these 2 GLP-1 RA therapies?
    Novo Nordisk, Inc., November 2019
  3. A choice of GLP-1 RA therapies
    Novo Nordisk, Inc., November 2019
  4. See which of these 2 GLP-1 RA therapies might be right for your adult patients with T2D
    Novo Nordisk, Inc., November 2019
  5. Novo Nordisk offers 2 Injectable GLP-1 RA therapies. See which one is for your adult patients with T2D
    Novo Nordisk, Inc., November 2019
  6. A Once-Weekly T2DM Tx Option from Novo Nordisk
    Novo Nordisk, Inc., November 2019
  7. Are your patients always missing a dose? Explore this GLP-1 RA therapy from Novo Nordisk
    Novo Nordisk, Inc., November 2019
  8. What's the next step for your adult patients with T2D who need A1C reduction and are concerned about weight? View Safety and Prescribing Info Including Boxed Warning
    Novo Nordisk, Inc., November 2019
  9. Have you considered a once-weekly GLP-1 RA to improve glycemic control for your patients? View Safety and Prescribing Info Including Boxed Warning
    Novo Nordisk, Inc., November 2019
  10. Consider what once-weekly injections could mean for your adult patients with T2D. Explore dosing schedule of this GLP-1 RA therapy. View Safety and Prescribing Info Including Boxed Warning
    Novo Nordisk, Inc., November 2019
  11. Are your adult patientswith T2D looking for glycemic control and once-weekly dosing? View Safety and Prescribing Info Including Boxed Warning
    Novo Nordisk, Inc., November 2019
  12. What could your adult patients with T2D who make the change to this GLP-1 RA theraphy expect? Check local coverage and patient support info. View Safety and Prescribing Info Including Boxed Warning
    Novo Nordisk, Inc., November 2019
  13. Consider this once-weekly GLP-1 RA therapy with appropriate patients. Order samples. View Safety and Prescribing Info Including Boxed Warning
    Novo Nordisk, Inc., November 2019
  14. Is a Once-Weekly T2DM Therapy an Option for your adult patients with T2D? View Safety and Prescribing Info Including Boxed Warning
    Novo Nordisk, Inc., November 2019
  15. Learn About A Non-Insulin Alternative Treatment for Type 2 Diabetes. Get Info on a GLP-1 Analog That Lowers Blood Sugar and A1C in Adults With T2D.
    Novo Nordisk, Inc., 2019
  16. Learn More About a Non-Insulin Therapy Option That Helps Control A1C & FPG. GLP-1 Analog Treatment for T2D that Lowers Blood Sugar and A1C.
    Novo Nordisk, Inc., 2019
  17. Find a Alternative Non-Insulin T2D Treatment Option Here. A GLP-1 Analog That Lowers Blood Sugar and A1C in Adults With Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  18. Diabetes Treatment Option: Non-Insulin Therapy. Get More Information on a GLP-1 Analog That Lowers Blood Sugar in Adults With Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  19. Learn About a Alternative Non-Insulin T2D Treatment. A Once-Daily Prefilled Pen That Lowers Blood Sugar and A1C in Adults with Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  20. Learn More About a Non-Insulin Treatment That May Help Lower A1C. Get the Information on a GLP-1 Analog That Lowers Blood Sugar in Adults With T2D.
    Novo Nordisk, Inc., 2019
  21. Learn About a Non-Insulin Treatment. Get More Information on a GLP-1 Analog for Type 2 Diabetes That Lowers Blood Sugar and A1C in Adults w/ T2D.
    Novo Nordisk, Inc., 2019

 

  1. Diabetes Treatment Information. Learn About a Alternative Non-Insulin Therapy That Lowers Blood Sugar and A1C in Adults with Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  2. Get More Information About a Non-Insulin Treatment That Lowers Blood Sugar and A1C in Adults With Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  3. Get More Information About a Non-Insulin Therapy That Reduces Blood Sugar and A1C in Adults With Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  4. Alternative T2D Treatment Options - Learn About a GLP-1 Analog That Lowers Blood Sugar and A1C in Adults with Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  5. A Once-Daily Non-Insulin Prefilled Pen. Learn About a GLP-1 Analog for Type 2 Diabetes That Lowers Blood Sugar and A1C in Adults with Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  6. Non-Insulin Treatment for T2D. Learn How a GLP-1 Analog That Lowers Blood Sugar and A1C in Adults with Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  7. Non-Insulin Therapy for T2D. Learn About a GLP-1 Analog That Reduces Glucagon Secretion & Lowers Blood Sugar in Adults with Type 2 Diabetes.
    Novo Nordisk, Inc., 2019
  8. Watch: HCPs from 4 different specialties discuss a GLP-1 RA therapy
    Novo Nordisk, Inc., 2019
  9. GLP-1 RA Peer Perspectives
    Novo Nordisk, Inc., 2019
  10. GLP-1 RA Peer Perspectives Treatment Evolution
    Novo Nordisk, Inc., 2019
  11. GLP-1 RA Peer Perspectives: Be Part of the Discussion
    Novo Nordisk, Inc., 2019
  12. GLP-1 RA Peer Perspectives: Treatment Guidelines
    Novo Nordisk, Inc., 2019
  13. GLP-1 RA Peer Perspectives: Patient Identification
    Novo Nordisk, Inc., 2019
  14. GLP-1 RA Peer Perspectives: Care Team Collaboration
    Novo Nordisk, Inc., 2019
  15. [VIDEO] How 4 HCPs treat T2D as a team
    Novo Nordisk, Inc., 2019
  16. [VIDEO] Your role in T2D care teams
    Novo Nordisk, Inc., 2019
  17. Are your T2D patients 65+ covered?
    Novo Nordisk, Inc., 2019
  18. GLP-1 RA therapy formulary coverage
    Novo Nordisk, Inc., 2019
  19. Do your Medicare Part D patients with T2D have coverage?
    Novo Nordisk, Inc., 2019
  20. Help Medicare Part D patients with T2D find out if coverage is available for this GLP-1 RA therapy.
    Novo Nordisk, Inc., 2019
  21. Victoza® Patient Support Program | Victoza® (liraglutide) injection 1.2mg or 1.8 mg? View Safety and Prescribing Info Including Boxed Warning
    Novo Nordisk, Inc., 2019
  22. Order Samples | Victoza® (liraglutide) injection 1.2mg or 1.8 mg? View Safety and Prescribing Info Including Boxed Warning
    Novo Nordisk, Inc., 2019